Understanding Severe Mosquito Bite Allergy & NK-Cell Lymphoproliferative Disorder

Hypersensitivity to mosquito bites (HMB) is a rare condition in which a mosquito bite triggers an exaggerated local reaction — intense swelling, blistering, ulceration, and sometimes fever — far beyond a typical bite reaction. In a notable subset of patients, this hypersensitivity occurs in the setting of an underlying Epstein-Barr virus (EBV)-driven NK-cell lymphoproliferative disorder, where EBV-infected NK-cells (and sometimes T-cells) expand abnormally. This association is most frequently described in children and young adults, particularly in East Asian populations, and requires careful hematologic evaluation because the underlying lymphoproliferative process can, in some patients, progress toward more aggressive EBV-associated NK/T-cell malignancies.

This condition exists along a spectrum, ranging from isolated severe skin hypersensitivity to a more systemic EBV-associated lymphoproliferative process.

Symptoms range from dramatic local skin reactions to systemic signs reflecting the underlying lymphoproliferative process.

This condition arises from an interplay between EBV infection of NK-cells and an exaggerated immune and allergic response to mosquito saliva antigens.

Diagnosis requires looking beyond the skin reaction to assess for underlying EBV infection and NK-cell lymphoproliferation.

There is no formal staging system; instead, patients are categorized by the degree of systemic involvement and risk of progression to a more aggressive lymphoproliferative disease.

Management is tailored to disease severity, ranging from symptomatic bite-reaction care to active treatment of the underlying EBV-driven lymphoproliferative process.

Because this disorder is EBV-driven, therapies targeting EBV-infected cells are an active area of research, particularly for patients who progress toward more aggressive disease.

EBV-related and NK-cell markers are central to diagnosing and monitoring this rare disorder.

This rare disorder benefits from evaluation by specialists experienced with EBV-associated lymphoproliferative diseases, since general allergy work-ups can miss the underlying process.

Outcomes vary considerably: many patients have a chronic but stable course limited to skin reactions, while a smaller subset experiences progression toward more aggressive disease that requires active treatment.

Supportive care focuses on minimizing bite exposure, managing skin symptoms, and addressing the anxiety that can come with a rare and poorly understood diagnosis.